美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kalaris Therapeutics Inc.

3.38

+0.08002.42%

盤後：3.480.1000+2.96%19:30 EDT

成交量：9.51萬

成交額：32.07萬

市值：8,041.79萬

市盈率：-1.64

高：3.44

開：3.39

低：3.27

收：3.30

52周最高：11.88

52周最低：3.03

股本：2,379.23萬

流通股本：723.08萬

量比：1.54

換手率：1.32%

股息：- -

股息率：- -

每股收益(TTM):-2.0646

每股收益(LYR):-2.8500

淨資產收益率：-79.91%

總資產收益率：-31.03%

市淨率：1.39

市盈率(LYR):-1.19

資料載入中...

總覽公司新聞公告

Kalaris Therapeutics Inc. 第二季度運營虧損低於預期，錄得1238.6萬美元

Kalaris Therapeutics 四個月後41%患者需再次治療，六個月內29%無需額外干預

Kalaris Therapeutics公布TH103治療新生血管性年齡相關性黃斑變性的1a期擴展隊列積極結果

新聞稿：Kalaris任命勞裏·基廷加入董事會

Kalaris宣佈將在美國視網膜專家學會公布TH103一期a階段臨床數據一期B/二期臨床試驗正積極招募

Kalaris Therapeutics Inc. 第一季度營業虧損達1183.3萬美元

Kalaris Therapeutics Inc任命Brett Hagen為首席財務官，自2026年4月14日起生效

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/KLRS/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KLRS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRS\",,,,,undefined,":{"symbol":"KLRS","market":"US","secType":"STK","nameCN":"Kalaris Therapeutics Inc.","latestPrice":3.38,"timestamp":1789156800000,"preClose":3.3,"halted":0,"volume":95102,"hourTrading":{"tag":"盘后","latestPrice":3.48,"preClose":3.38,"latestTime":"19:30 EDT","volume":8017,"amount":27893.234,"timestamp":1789169404829,"change":0.1,"changeRate":0.029586,"amplitude":0.029586},"delay":0,"changeRate":0.024242424242424267,"floatShares":7230800,"shares":23792278,"eps":-2.064571,"marketStatus":"休市中","change":0.08,"latestTime":"09-11 16:00:00 EDT","open":3.39,"high":3.44,"low":3.27,"amount":320726.977655,"amplitude":0.051515,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.064571,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1596081600000,"exchange":"NASDAQ","adjPreClose":3.3,"postHourTrading":{"tag":"盘后","latestPrice":3.48,"preClose":3.38,"latestTime":"19:30 EDT","volume":8017,"amount":27893.234,"timestamp":1789169404829,"change":0.1,"changeRate":0.029586,"amplitude":0.029586},"volumeRatio":1.5419962188648166},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRS\",,,,,undefined,":{"symbol":"KLRS","floatShares":7230800,"roa":"-31.03%","roe":"-79.91%","lyrEps":-2.849999,"volumeRatio":1.5419962188648166,"shares":23792278,"dividePrice":0,"high":3.44,"amplitude":0.051515,"preClose":3.3,"low":3.27,"week52Low":3.03,"pbRate":"1.39","week52High":11.88,"institutionHeld":0,"latestPrice":3.38,"eps":-2.064571,"divideRate":0,"volume":95102,"delay":0,"ttmEps":-2.064571,"open":3.39,"prevYearClose":8.44,"prevWeekClose":3.9,"prevMonthClose":4.04,"prevQuarterClose":4.07,"fiveDayClose":3.94,"twentyDayClose":3.88,"sixtyDayClose":4.37},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KLRS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"KLRS","fiscalQuarterEnding":"2026/06","expectedEps":-0.5,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2026-05-12","symbol":"KLRS","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2026-03-17","symbol":"KLRS","fiscalQuarterEnding":"2025/12","expectedEps":-0.56,"name":null,"time":"盤前","type":"earning","dateTimestamp":1773720000000,"reportTimeType":"pre","actualEps":-0.44},{"market":"US","date":"2025-11-12","symbol":"KLRS","fiscalQuarterEnding":"2025/09","expectedEps":-0.66,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.64},{"market":"US","date":"2025-08-13","symbol":"KLRS","fiscalQuarterEnding":"2025/06","expectedEps":-0.51,"name":null,"time":"盤前","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KLRS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KLRS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.375,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1781582400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KLRS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KLRS","date":"2026-09-11","current":-1.637144,"percent":0.621253,"low":-3.702314,"twenty":-2.976168,"median":-2.131838,"eighty":-0.8745,"high":-0.558935,"avg":-1.982735,"sd":0.95633,"marketCap":78556437},"quantilePoints":[{"date":"2025-03-28","current":-2.436259,"twenty":-2.629862,"median":-2.463299,"eighty":-2.415709,"marketCap":168508741},{"date":"2025-04-04","current":-2.000923,"twenty":-2.457891,"median":-2.325397,"eighty":-2.168027,"marketCap":138397856},{"date":"2025-04-11","current":-1.976588,"twenty":-2.405434,"median":-2.167216,"eighty":-1.951712,"marketCap":136714639},{"date":"2025-04-17","current":-1.811647,"twenty":-2.361089,"median":-2.042834,"eighty":-1.880868,"marketCap":125306167},{"date":"2025-04-25","current":-1.762976,"twenty":-2.268073,"median":-1.954956,"eighty":-1.818136,"marketCap":121939732},{"date":"2025-05-02","current":-1.581811,"twenty":-2.177762,"median":-1.903581,"eighty":-1.797045,"marketCap":109409116},{"date":"2025-05-09","current":-1.041021,"twenty":-2.168027,"median":-1.865726,"eighty":-1.715927,"marketCap":72004290},{"date":"2025-05-16","current":-0.871644,"twenty":-2.131794,"median":-1.821111,"eighty":-1.36225,"marketCap":66206559},{"date":"2025-05-23","current":-0.696822,"twenty":-2.051217,"median":-1.811647,"eighty":-0.924751,"marketCap":52927842},{"date":"2025-05-30","current":-0.728832,"twenty":-1.996056,"median":-1.784607,"eighty":-0.873072,"marketCap":55359157},{"date":"2025-06-06","current":-0.765766,"twenty":-1.972262,"median":-1.721064,"eighty":-0.77266,"marketCap":58164519},{"date":"2025-06-13","current":-0.679587,"twenty":-1.946844,"median":-1.576403,"eighty":-0.758379,"marketCap":51618673},{"date":"2025-06-20","current":-0.632803,"twenty":-1.914397,"median":-1.295192,"eighty":-0.733756,"marketCap":48065214},{"date":"2025-06-27","current":-0.630341,"twenty":-1.911693,"median":-0.990998,"eighty":-0.714058,"marketCap":47878190},{"date":"2025-07-03","current":-0.615567,"twenty":-1.898714,"median":-0.913935,"eighty":-0.685496,"marketCap":46756045},{"date":"2025-07-11","current":-0.615567,"twenty":-1.891143,"median":-0.871644,"eighty":-0.649054,"marketCap":46756045},{"date":"2025-07-18","current":-0.595869,"twenty":-1.870593,"median":-0.816242,"eighty":-0.639205,"marketCap":45259851},{"date":"2025-07-25","current":-0.699285,"twenty":-1.8614,"median":-0.765766,"eighty":-0.634773,"marketCap":53114867},{"date":"2025-08-01","current":-0.659888,"twenty":-1.83436,"median":-0.758379,"eighty":-0.635266,"marketCap":50122480},{"date":"2025-08-08","current":-0.667275,"twenty":-1.817055,"median":-0.738681,"eighty":-0.635266,"marketCap":50683552},{"date":"2025-08-15","current":-0.558935,"twenty":-1.812188,"median":-0.724523,"eighty":-0.632803,"marketCap":42454488},{"date":"2025-08-22","current":-0.563436,"twenty":-1.811647,"median":-0.714058,"eighty":-0.627879,"marketCap":46007948},{"date":"2025-08-29","current":-0.815379,"twenty":-1.792178,"median":-0.714058,"eighty":-0.615567,"marketCap":66580608},{"date":"2025-09-05","current":-1.067322,"twenty":-1.785689,"median":-0.715289,"eighty":-0.622954,"marketCap":87153267},{"date":"2025-09-12","current":-0.980287,"twenty":-1.771628,"median":-0.728832,"eighty":-0.627879,"marketCap":80046349},{"date":"2025-09-19","current":-1.005482,"twenty":-1.753242,"median":-0.746068,"eighty":-0.629356,"marketCap":82103615},{"date":"2025-09-26","current":-1.092517,"twenty":-1.715927,"median":-0.758379,"eighty":-0.630341,"marketCap":89210533},{"date":"2025-10-03","current":-1.623887,"twenty":-1.652483,"median":-0.783002,"eighty":-0.631818,"marketCap":132600143},{"date":"2025-10-10","current":-1.059306,"twenty":-1.715927,"median":-0.815379,"eighty":-0.632803,"marketCap":86498683},{"date":"2025-10-17","current":-1.097097,"twenty":-1.652483,"median":-0.853303,"eighty":-0.634281,"marketCap":89584582},{"date":"2025-10-24","current":-1.120001,"twenty":-1.598641,"median":-0.878784,"eighty":-0.635266,"marketCap":91454824},{"date":"2025-10-31","current":-1.085645,"twenty":-1.578566,"median":-0.913935,"eighty":-0.635266,"marketCap":88649461},{"date":"2025-11-07","current":-1.083355,"twenty":-1.543053,"median":-0.93448,"eighty":-0.63822,"marketCap":88462437},{"date":"2025-11-14","current":-1.220778,"twenty":-1.513949,"median":-0.991739,"eighty":-0.641667,"marketCap":99683887},{"date":"2025-11-21","current":-2.326591,"twenty":-1.652483,"median":-1.007772,"eighty":-0.642652,"marketCap":129046684},{"date":"2025-11-28","current":-2.104047,"twenty":-1.7661,"median":-1.019224,"eighty":-0.643637,"marketCap":116703088},{"date":"2025-12-05","current":-1.996147,"twenty":-1.811647,"median":-1.04043,"eighty":-0.647085,"marketCap":110718314},{"date":"2025-12-12","current":-2.808768,"twenty":-1.83375,"median":-1.046709,"eighty":-0.650039,"marketCap":155791141},{"date":"2025-12-19","current":-3.513489,"twenty":-1.853956,"median":-1.059878,"eighty":-0.652009,"marketCap":194879195},{"date":"2025-12-26","current":-3.230252,"twenty":-1.885652,"median":-1.065031,"eighty":-0.655456,"marketCap":179169164},{"date":"2026-01-02","current":-2.845859,"twenty":-1.914397,"median":-1.075338,"eighty":-0.657426,"marketCap":157848407},{"date":"2026-01-09","current":-2.785165,"twenty":-1.996147,"median":-1.083355,"eighty":-0.657426,"marketCap":154481972},{"date":"2026-01-16","current":-2.987477,"twenty":-2.104047,"median":-1.089081,"eighty":-0.657426,"marketCap":165703423},{"date":"2026-01-23","current":-3.29769,"twenty":-2.164782,"median":-1.092517,"eighty":-0.659396,"marketCap":182909648},{"date":"2026-01-30","current":-3.102121,"twenty":-2.196152,"median":-1.097097,"eighty":-0.661858,"marketCap":172062245},{"date":"2026-02-06","current":-2.815512,"twenty":-2.367922,"median":-1.114275,"eighty":-0.662351,"marketCap":156165190},{"date":"2026-02-13","current":-3.02794,"twenty":-2.502772,"median":-1.122292,"eighty":-0.662351,"marketCap":167947713},{"date":"2026-02-20","current":-3.702314,"twenty":-2.785165,"median":-1.136034,"eighty":-0.665305,"marketCap":205352549},{"date":"2026-02-27","current":-3.560695,"twenty":-2.810117,"median":-1.145196,"eighty":-0.674662,"marketCap":197497534},{"date":"2026-03-06","current":-3.262285,"twenty":-2.841832,"median":-1.152067,"eighty":-0.679587,"marketCap":180945894},{"date":"2026-03-13","current":-3.092005,"twenty":-2.933528,"median":-1.165399,"eighty":-0.681064,"marketCap":171501173},{"date":"2026-03-20","current":-2.932075,"twenty":-2.973316,"median":-1.284909,"eighty":-0.685003,"marketCap":127363466},{"date":"2026-03-27","current":-3.072027,"twenty":-2.992198,"median":-1.357057,"eighty":-0.692882,"marketCap":133442723},{"date":"2026-04-02","current":-3.132729,"twenty":-3.014452,"median":-1.458617,"eighty":-0.697807,"marketCap":136079478},{"date":"2026-04-10","current":-3.203987,"twenty":-3.059472,"median":-1.52082,"eighty":-0.701747,"marketCap":139174799},{"date":"2026-04-17","current":-3.478464,"twenty":-3.075922,"median":-1.602849,"eighty":-0.708887,"marketCap":151097516},{"date":"2026-04-24","current":-3.219822,"twenty":-3.095853,"median":-1.746752,"eighty":-0.714058,"marketCap":139862648},{"date":"2026-05-01","current":-2.913675,"twenty":-3.10064,"median":-1.776394,"eighty":-0.714058,"marketCap":126564232},{"date":"2026-05-08","current":-2.725961,"twenty":-3.095853,"median":-1.811647,"eighty":-0.715043,"marketCap":118410298},{"date":"2026-05-15","current":-2.72166,"twenty":-3.087959,"median":-1.820952,"eighty":-0.717998,"marketCap":120019759},{"date":"2026-05-22","current":-2.669521,"twenty":-3.080541,"median":-1.83767,"eighty":-0.723661,"marketCap":117720529},{"date":"2026-05-29","current":-2.700804,"twenty":-3.078518,"median":-1.841041,"eighty":-0.729817,"marketCap":119100067},{"date":"2026-06-05","current":-2.429681,"twenty":-3.07722,"median":-1.863022,"eighty":-0.734741,"marketCap":107144076},{"date":"2026-06-12","current":-2.352359,"twenty":-3.072027,"median":-1.890061,"eighty":-0.741636,"marketCap":103734332},{"date":"2026-06-18","current":-2.45487,"twenty":-3.072027,"median":-1.911693,"eighty":-0.753455,"marketCap":108254864},{"date":"2026-06-26","current":-2.319987,"twenty":-3.071774,"median":-1.965772,"eighty":-0.758379,"marketCap":102306795},{"date":"2026-07-02","current":-2.44408,"twenty":-3.063682,"median":-1.990247,"eighty":-0.758379,"marketCap":107779019},{"date":"2026-07-10","current":-2.422498,"twenty":-3.057285,"median":-2.077072,"eighty":-0.760349,"marketCap":106827328},{"date":"2026-07-17","current":-2.487242,"twenty":-3.052473,"median":-2.104047,"eighty":-0.764781,"marketCap":109682401},{"date":"2026-07-24","current":-2.114965,"twenty":-3.046817,"median":-2.114965,"eighty":-0.793344,"marketCap":93265729},{"date":"2026-07-31","current":-1.877571,"twenty":-3.035018,"median":-2.104047,"eighty":-0.807625,"marketCap":82797127},{"date":"2026-08-07","current":-2.260639,"twenty":-3.007709,"median":-2.112878,"eighty":-0.814247,"marketCap":99689644},{"date":"2026-08-14","current":-2.08558,"twenty":-2.992198,"median":-2.117831,"eighty":-0.818113,"marketCap":92314038},{"date":"2026-08-21","current":-2.215768,"twenty":-2.988826,"median":-2.131838,"eighty":-0.837815,"marketCap":98076521},{"date":"2026-08-28","current":-2.205011,"twenty":-2.983431,"median":-2.16316,"eighty":-0.854016,"marketCap":97600422},{"date":"2026-09-04","current":-2.118962,"twenty":-2.978711,"median":-2.160644,"eighty":-0.865734,"marketCap":93791625},{"date":"2026-09-11","current":-1.774765,"twenty":-2.976168,"median":-2.131838,"eighty":-0.8745,"marketCap":78556437}],"updateTime":1789340195256},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KLRS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1178929389","title":"Kalaris Therapeutics Inc. 第二季度運營虧損低於預期，錄得1238.6萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178929389","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178929389?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 20:15","pubTimestamp":1786450532,"startTime":"0","endTime":"0","summary":"Kalaris Therapeutics Inc. 公布的第二季度运营数据出炉。本季度运营支出为1238.6万美元，而运营收入则为-1238.6万美元。\n对比业内普遍预期（IBES预估为-1250万美元），公司实际亏损略低于这一数字，展现出相对稳健的财务表现。\n这一数据为投资者提供了关于公司近期经营状况的重要参考。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194705815","title":"Kalaris Therapeutics 四個月後41%患者需再次治療，六個月內29%無需額外干預","url":"https://stock-news.laohu8.com/highlight/detail?id=1194705815","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194705815?lang=zh_tw&edition=fundamental","pubTime":"2026-07-17 19:02","pubTimestamp":1784286160,"startTime":"0","endTime":"0","summary":"Kalaris Therapeutics公布的数据显示，在接受其疗法后四个月或更晚时间点，有41%的患者需要接受再次治疗。然而，在为期六个月的观察期内，有29%的患者未再需要任何额外的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123151126","title":"Kalaris Therapeutics公布TH103治療新生血管性年齡相關性黃斑變性的1a期擴展隊列積極結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1123151126","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123151126?lang=zh_tw&edition=fundamental","pubTime":"2026-07-17 19:01","pubTimestamp":1784286076,"startTime":"0","endTime":"0","summary":"Kalaris Therapeutics Inc. (KLRS) 宣布，其候选药物TH103在治疗新生血管性年龄相关性黄斑变性的1a期临床试验扩展队列中，取得了积极的初步数据。结果显示，TH103表现出良好的安全性与耐受性特征，并为后续临床开发提供了支持性依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLRS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165872790","title":"新聞稿：Kalaris任命勞裏·基廷加入董事會","url":"https://stock-news.laohu8.com/highlight/detail?id=1165872790","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165872790?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:07","pubTimestamp":1783368475,"startTime":"0","endTime":"0","summary":"新泽西州伯克利高地，2026年7月6日——致力于研发和商业化治疗常见视网膜疾病的临床阶段生物制药公司Kalaris Therapeutics, Inc.今日宣布，任命劳里·基廷加入其董事会，自2026年8月1日起生效。伴随基廷女士的任命公告，莫拉娜·约万-埃姆比里科斯将辞去董事会职务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130870385","title":"Kalaris宣佈將在美國視網膜專家學會公布TH103一期a階段臨床數據 一期B/二期臨床試驗正積極招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1130870385","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130870385?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 20:02","pubTimestamp":1782216174,"startTime":"0","endTime":"0","summary":"Kalaris Therapeutics Inc. 宣布，其候选药物TH103的一期a阶段临床数据即将在美国视网膜专家学会年会上公布。与此同时，该药物后续的一期B/二期临床试验也正在积极进行患者招募工作。目前正在推进的一期B/二期临床试验旨在进一步评估TH103的疗效与安全性，其积极招募状态也反映了公司对该项目持续推进的决心。业内普遍关注此类创新疗法的临床进展，因其可能为存在未满足医疗需求的视网膜疾病患者带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187520500","title":"Kalaris Therapeutics Inc. 第一季度營業虧損達1183.3萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187520500","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187520500?lang=zh_tw&edition=fundamental","pubTime":"2026-05-12 20:16","pubTimestamp":1778588187,"startTime":"0","endTime":"0","summary":"Kalaris Therapeutics Inc. 最新财报数据显示，该公司第一季度营业费用为1183.3万美元，导致同期营业亏损达到同等数额。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLRS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199365025","title":"Kalaris Therapeutics Inc任命Brett Hagen為首席財務官，自2026年4月14日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1199365025","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199365025?lang=zh_tw&edition=fundamental","pubTime":"2026-04-11 04:24","pubTimestamp":1775852653,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，生物制药公司Kalaris Therapeutics Inc. (KLRS) 已正式任命Brett Hagen先生担任公司首席财务官（Principal Financial Officer），此项任命将于2026年4月14日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLRS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}